Two clot-retrievers versus one for acute stroke treatment
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares using two clot-retrievers at the same time versus using just one to remove the clot in an acute ischemic stroke. It may help find a more effective approach to restore blood flow and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new, disabling stroke symptom on one side (or focal brain symptoms) that started recently
- The stroke team must confirm a clot blockage in a specific artery (terminal internal carotid, middle cerebral, or basilar)
- Treatment must start within 24 hours of symptom onset (time of first symptoms)
- Brain CT scan must show enough healthy tissue (ASPECTS score 6 or higher)
- Your baseline disability level before this stroke must be low (mRS 0 to 2)
- There should not be major bleeding or dangerous swelling/shifting of the brain on the baseline CT
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a procedure to remove a large blood clot from the brain (thrombectomy) with standard medical care for people who had a stroke 24 to 72 hours ago but still have some blood flow around the clot. It aims to see if the procedure can help improve recovery even when started later than usual.
This trial tests whether removing a blood clot from a large brain artery is better than standard medical care for people who have a mild stroke (NIHSS score 2-5) but still have symptoms like trouble speaking, weakness, or confusion. It is for patients who can be treated within 24 hours of their last known well time.
This trial tests whether giving a clot-busting drug (alteplase) directly into the brain artery after a successful clot removal improves recovery in people with severe stroke. It is for patients who have had a thrombectomy and still have a large blocked artery in the front of the brain.
This trial tests a specialized clot-removal treatment for people who had a mild but disabling stroke up to 24 hours ago and have a large artery blockage in the brain. The goal is to see if this precision therapy can help reduce disability and improve recovery.
This trial tests whether giving a clot-busting medication (tenecteplase) intravenously before mechanical thrombectomy—a procedure to physically remove a large blood clot from the brain—improves recovery better than thrombectomy alone in patients with large ischemic strokes.
This trial compares two methods for removing blood clots from arteries in the brain during an acute stroke: aspiration (suction) versus stent retriever (a mesh device). The goal is to see which approach works better for patients treated within 24 hours of stroke symptoms.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.